This comprehensive study offers significant insights into the potential application of a novel SAW microchip for the early detection of DR in individuals with diabetes. By utilizing protein biomarkers found in tear fluid, the device facilitates noninvasive, rapid, and sensitive detection, potentially revolutionizing DR diagnostics and improving patient outcomes through timely intervention and management of this vision-threatening condition.
Keyphrases
- sensitive detection
- diabetic retinopathy
- loop mediated isothermal amplification
- quantum dots
- optical coherence tomography
- editorial comment
- type diabetes
- randomized controlled trial
- cardiovascular disease
- adipose tissue
- insulin resistance
- metabolic syndrome
- protein protein
- risk assessment
- small molecule
- human health